Valiant Laboratories Ltd

At Rs 128.88, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Valiant Laboratories Ltd locked at its upper circuit of 5% on 18 Sep 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 122.5, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Valiant Laboratories Ltd locked at its upper circuit of 4.78% on 17 Sep 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 116.5, sellers were still queuing — but there were no buyers willing to take the other side. Valiant Laboratories Ltd locked at its lower circuit of 5.0% on 16 Sep 2026, with unfilled sell orders and a frozen price, reflecting a day where supply overwhelmed demand to the point where the circuit breaker intervened.

Valiant Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend, amid a complex interplay of technical indicators. Despite a recent 5.00% decline in the stock price to ₹121.11, the company’s technical profile reveals a nuanced picture with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, suggesting cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.

At Rs 121.52, sellers were still queuing — but there were no buyers willing to take the other side. Valiant Laboratories Ltd locked at its lower circuit of 5.0% on 15 Sep 2026, with unfilled sell orders and a frozen price.

After a sustained rally that has seen Valiant Laboratories Ltd gain 39.3% over the past eight trading days, the stock surged to a fresh 52-week high of Rs 130 on 11 Sep 2026, outpacing its sector and broader market indices despite a volatile session.

Valiant Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.

At Rs 118.56, Valiant Laboratories Ltd locked at its lower circuit limit of 5.0% on 11 Sep 2026, with persistent selling pressure and no buyers willing to absorb the supply. The unfilled sell orders created a freeze in trading, highlighting the challenges faced by sellers in exiting positions at these levels.

At Rs 125.82, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Valiant Laboratories Ltd locked at its upper circuit of 5% on 10 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Surging past its previous peaks, Valiant Laboratories Ltd touched a fresh 52-week high of Rs 125.65 on 10 Sep 2026, marking a remarkable rally from its 52-week low of Rs 50. This milestone caps a seven-day winning streak that has propelled the stock up by 35.57%, significantly outperforming its sector and the broader market.

Valiant Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable shift in price momentum and technical indicators, prompting an upgrade in its Mojo Grade from Sell to Hold. The stock’s recent performance, coupled with mixed but improving technical signals, suggests a cautiously optimistic outlook for investors.

Valiant Laboratories Ltd has achieved a significant milestone by reaching a new 52-week high of Rs.119.67 on 09 Sep 2026, marking a notable surge in the stock’s momentum amid a challenging broader market environment.

At Rs 119.83, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Valiant Laboratories Ltd locked at its upper circuit of 4.99% on 9 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Valiant Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum following a robust price surge to its 52-week high of ₹113.98. The stock’s recent performance, coupled with mixed signals from key technical indicators, suggests a nuanced outlook for investors navigating this evolving landscape.

Surging past its previous peaks, Valiant Laboratories Ltd reached a fresh 52-week high of Rs 113.98 on 8 Sep 2026, marking a remarkable rally from its 52-week low of Rs 50. This milestone caps a sustained five-day winning streak that has delivered nearly 23% returns, underscoring the stock’s strong price momentum amid a broader market downturn.

At Rs 114.13, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Valiant Laboratories Ltd locked at its upper circuit of 5% on 8 Sep 2026, with buyers queuing and no sellers willing to part with shares.

With a sustained rally pushing Valiant Laboratories Ltd to an intraday peak of Rs 110.76, the stock has reached a fresh 52-week high on 7 Sep 2026, marking a significant milestone in its upward trajectory amid a challenging broader market environment.